Cargando…

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

Osteosarcoma is the most common primary malignancy of the skeleton and is prevalent in children and adolescents. Survival rates are poor and have remained stagnant due to chemoresistance and the high propensity to form lung metastases. In this study, we used in vivo transgenic models of c-fos oncoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weekes, Daniel, Kashima, Takeshi G, Zandueta, Carolina, Perurena, Naiara, Thomas, David P, Sunters, Andrew, Vuillier, Céline, Bozec, Aline, El-Emir, Ethaar, Miletich, Isabelle, Patiño-Garcia, Ana, Lecanda, Fernando, Grigoriadis, Agamemnon E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688957/ https://www.ncbi.nlm.nih.gov/pubmed/26387545 http://dx.doi.org/10.1038/onc.2015.344

Ejemplares similares

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
por: Perurena, Naiara, et al.
Publicado: (2017)

Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma
por: Rodríguez-Nogales, Carlos, et al.
Publicado: (2020)

Bone cell differentiation and the role of Fos/AP-1 proteins
por: Wagner, E, et al.
Publicado: (2003)

A specific role for phosphoinositide 3-kinase and AKT in osteoblasts?
por: McGonnell, Imelda M., et al.
Publicado: (2012)

An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer
por: Vallejo, Adrian, et al.
Publicado: (2017)

CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process
por: Habel, Nadia, et al.
Publicado: (2019)

Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription
Publicado: (1992)

Expression of c-fos and AP-1 activity in senescent human fibroblasts is not sufficient for DNA synthesis
Publicado: (1992)

Products of the fos and jun proto-oncogenes bind cooperatively to the AP1 DNA recognition sequence.
por: Risse, G, et al.
Publicado: (1990)

AP-1/c-Fos supports SIV and HIV-1 latency in CD4 T cells infected in vivo
por: Cobos Jiménez, Viviana, et al.
Publicado: (2023)

Truncated and Helix-Constrained Peptides with High Affinity and Specificity for the cFos Coiled-Coil of AP-1
por: Rao, Tara, et al.
Publicado: (2013)

Recurrent rearrangements of FOS and FOSB define osteoblastoma
por: Fittall, Matthew W., et al.
Publicado: (2018)

A Novel Mouse c-fos Intronic Promoter That Responds to CREB and AP-1 Is Developmentally Regulated In Vivo
por: Coulon, Vincent, et al.
Publicado: (2010)

The FGFR1 inhibitor PD173074 induces mesenchymal–epithelial transition through the transcription factor AP-1
por: Nguyen, P T, et al.
Publicado: (2013)

Silencing of FOS-like antigen 1 represses restenosis via the ERK/AP-1 pathway in type 2 diabetic mice
por: Zhou, Chaoxi, et al.
Publicado: (2021)

FOS Rescues Neuronal Differentiation of Sox2-Deleted Neural Stem Cells by Genome-Wide Regulation of Common SOX2 and AP1(FOS-JUN) Target Genes
por: Pagin, Miriam, et al.
Publicado: (2021)

The Function of Heterodimeric AP-1 Comprised of c-Jun and c-Fos in Activin Mediated Spemann Organizer Gene Expression
por: Lee, Sung-Young, et al.
Publicado: (2011)

Endogenous authentic OCT4A proteins directly regulate FOS/AP-1 transcription in somatic cancer cells
por: Zhou, Yanwen, et al.
Publicado: (2018)

Transcriptional activation of Jun and Fos members of the AP‐1 complex is a conserved signature of immune aging that contributes to inflammaging
por: Karakaslar, Emin Onur, et al.
Publicado: (2023)

AP-1 Transcription Factor Complex Members FOSB and FOS are Linked With CNS Infiltration and Inferior Prognosis in Childhood T-ALL
por: Spory, Lea, et al.
Publicado: (2023)

Myristylation of FBR v-fos dictates the differentiation pathways in malignant osteosarcoma
Publicado: (1996)

Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope
por: González, José María, et al.
Publicado: (2008)

HPV16E6-Dependent c-Fos Expression Contributes to AP-1 Complex Formation in SiHa Cells
por: Liang, Feixin, et al.
Publicado: (2011)

The Transcription Factor FRA-1/AP-1 Controls Lipocalin-2 Expression and Inflammation in Sepsis Model
por: Cao, Shan, et al.
Publicado: (2021)

Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance
por: Habel, N, et al.
Publicado: (2013)

Wnt signaling and Loxl2 promote aggressive osteosarcoma
por: Matsuoka, Kazuhiko, et al.
Publicado: (2020)

Regulation of Jun and Fos AP-1 transcription factors by JNK MAPKs signaling cascade in areca nut extract treated KB cells
por: Nagesh, Rashmi, et al.
Publicado: (2021)

FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo
por: Brun, Julia, et al.
Publicado: (2013)

miRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma
por: Gao, Gan, et al.
Publicado: (2018)

Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope
por: Garcia-Moure, Marc, et al.
Publicado: (2016)

Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production
por: Bozec, Aline, et al.
Publicado: (2010)

The Evaluation of FGFR1, FGFR2 and FOXO1 in Orofacial Cleft Tissue
por: Goida, Jana, et al.
Publicado: (2022)

A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity
por: Greco, Francesco, et al.
Publicado: (2023)

Circ_0000885 Enhances Osteosarcoma Progression by Increasing FGFR1 Expression via Sponging MiR-1294
por: Chen, Yinxian, et al.
Publicado: (2020)

The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models
por: Martín-Fernández, Marta, et al.
Publicado: (2017)

Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534)
por: Li, Samuel Q., et al.
Publicado: (2013)

IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9
por: Huang, Qiaojia, et al.
Publicado: (2014)

Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype
por: Bleau, Anne-Marie, et al.
Publicado: (2015)

LMNA Reduced Acquired Resistance to Erlotinib in NSCLC by Reversing the Epithelial–Mesenchymal Transition via the FGFR/MAPK/c-fos Signaling Pathway
por: Hu, Chunsheng, et al.
Publicado: (2022)

FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer
por: Yang, Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i2kcu9d05u67om66hd8nngbmnt